Učitavanje...
No difference in persistence to treatment with atazanavir or darunavir in HIV patients in a real-world setting
INTRODUCTION: There is a lack of data comparing the protease inhibitors (PIs) atazanavir (ATV) and darunavir (DRV) in a real-world setting. This study compared persistence (time to switch/discontinuation) to therapy between ATV-treated and DRV-treated patients with human immunodeficiency virus (HIV)...
Spremljeno u:
| Izdano u: | J Int AIDS Soc |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
International AIDS Society
2014
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4224837/ https://ncbi.nlm.nih.gov/pubmed/25394047 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7448/IAS.17.4.19538 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|